Association of the dihydrolipoamide dehydrogenase gene with Alzheimer's disease in an Ashkenazi Jewish population

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 131 B, Issue 1, 2004, Pages 60-66

  Brown, Abraham M ^a,b   Gordon, Derek ^c   Lee, Hsinhwa ^a   Caudy, Michael ^a,b   Hardy, John ^d   Haroutunian, Vahram ^e,f   Blass, John P ^a,b  

^a BURKE MEDICAL RESEARCH INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; DIHYDROLIPOAMIDE DEHYDROGENASE; OXOGLUTARATE DEHYDROGENASE;

AGED; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; CAUCASIAN; CHROMOSOME 7; CONTROLLED STUDY; DENATURATION; DISABILITY; DNA FLANKING REGION; ENZYME ACTIVITY; EXON; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; JEW; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; DIHYDROLIPOAMIDE DEHYDROGENASE; EXONS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; JEWS; LOGISTIC MODELS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 7644243802     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30008     Document Type: Article

References (48)

1. Agresti A. 2002. Categorical data analysis. Hoboken: John Wiley and Sons, p 710.
2. Akaike H. 1973. Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Csaki F, editors. 2nd International Symposium on Information Theory. Budapest: Akademia Kiado. pp 267-281.
3. Bassett SS, Avramopoulos D, Fallin D. 2002. Evidence for parent of origin effect in late-onset Alzheimer disease. Am J Med Genet 114(6): 679-686.
4. Bergem AL, Engedal K, Kringlen E. 1997. The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study. Arch Gen Psychiatry 54(3):264-270.
5. Blass JP. 2002. Glucose/mitochondria in neurological conditions. Int Rev Neurobiol 51:325-376.
6. Cochran WG. 1952. The chi-square test of goodness of fit. Ann Math Stat 23(3):315-345.
7. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families [comment]. Science 261(5123):921-923.
8. Gibson GE, Sheu KF, Blass JP, Baker A, Carlson KC, Harding B, Perrino P. 1988. Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch Neurol 45(8):836-840.
9. Gibson GE, Sheu KF, Blass JP. 1998. Abnormalities of mitochondrial enzymes in Alzheimer disease. J Neural Transm 105(8-9):855-870.
10. Gibson GE, Haroutunian V, Zhang H, Park LC, Shi Q, Lesser M, Mohs RC, Sheu RK, Blass JP. 2000. Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype. Ann Neurol 48(3):297-303.
11. Gordon D, Simonic I, Ott J. 2000. Significant evidence for linkage disequilibrium over a 5-cM region among Afrikaners. Genomics 66(1): 87-92.
12. Guo SW, Thompson EA. 1992. Performing the exact test of Hardy- Weinberg proportion for multiple alleles. Biometrics 48(2):361-372.
13. Haroutunian V, Perl DP, Purohit DP, Marin D, Khan K, Lantz M, Davis KL, Mohs RC. 1998. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch Neurol 55(9):1185-1191.
14. Hirano M, Shtilbans A, Mayeux R, Davidson MM, DiMauro S, Knowles JA, Schon EA. 1997. Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes. Proc Natl Acad Sci USA 94(26): 14894-14899.
15. Hong YS, Kerr DS, Craigen WJ, Tan J, Pan Y, Lusk M, Patel MS. 1996. Identification of two mutations in a compound heterozygous child with dihydrolipoamide dehydrogenase deficiency. Hum Mol Genet 5(12): 1925-1930.
16. Hong YS, Kerr DS, Liu TC, Lusk M, Powell BR, Patel MS. 1997. Deficiency of dihydrolipoamide dehydrogenase due to two mutant alleles (E340K and G101del). Analysis of a family and prenatal testing. Biochimica et Biophysica Acta 1362(2-3):160-168.
17. Hoogendoorn B, Norton N, Kirov G, Williams N, Hamshere ML, Spurlock G, Austin J, Stephens MK, Buckland PR, Owen MJ, et al. 2000. Cheap, accurate, and rapid allele frequency estimation of single nucleotide polymorphisms by primer extension and DHPLC in DNA pools. Hum Genet 107(5):488-493.
18. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J, Gogos JA. 1997. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci USA 94(9):4572-4575.
19. Karayiorgou M, Sobin C, Blundell ML, Galke BL, Malinova L, Goldberg P, Ott J, Gogos JA. 1999. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry 45(9):1178-1189.
20. Kurosinski P, Guggisberg M, Gotz J. 2002. Alzheimer's and Parkinson's disease-overlapping or synergistic pathologies? Trends Mol Med 8(1): 3-5.
21. Lewontin RC. 1964. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 49:49-67.
22. Lissens W, De Meirleir L, Seneca S, Liebaers I, Brown GK, Brown RM, Ito M, Naito E, Kuroda Y, Kerr DS, et al. 2000. Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency. Hum Mutat 15(3): 209-219.
23. Liu TC, Kim H, Arizmendi C, Kitano A, Patel MS. 1993. Identification of two missense mutations in a dihydrolipoamide dehydrogenase-deficient patient. Proc Natl Acad Sci USA 90(11):5186-5190.
24. Mantel N, Haenszel W. 1959. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748.
25. Mastrogiacoma F, Lindsay JG, Bettendorff L, Rice J, Kish SJ. 1996. Brain protein and alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. Ann Neurol 39:592-598.
26. Meyer JM, Breitner JC. 1998. Multiple threshold model for the onset of Alzheimer's disease in the NAS-NRC twin panel. Am J Med Genet 81(1): 92-97.
27. Moraes CT, Shanske S, Tritschler HJ, Aprille JR, Andreetta F, Bonilla E, Schon EA, DiMauro S. 1991. mtDNA depletion with variable tissue expression: A novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 48(3):492-501.
28. Morris JC, Ernesto C, Schafer K, Coats M, Leon S, Sano M, Thal LJ, Woodbury P. 1997. Clinical dementia rating training and reliability in multicenter studies: The Alzheimer's Disease Cooperative Study experience. Neurology 48(6):1508-1510.
29. Myers A, Wavrant De-Vrieze F, Holmans P, Hamshere M, Crook R, Compton D, Marshall H, Meyer D, Shears S, Booth J, et al. 2002. Full genome screen for Alzheimer disease: Stage II analysis. Am J Med Genet 114(2): 235-244.
30. Ott J. 1999. Analysis of human genetic linkage. Baltimore: The Johns Hopkins University Press.
31. Parra D, Gonzalez A, Mugueta C, Martinez A, Monreal I. 2001. Laboratory approach to mitochondrial diseases. J Physiol Biochem 57(3):267-284.
32. Pedersen NL, Posner SF, Gatz M. 2001. Multiple-threshold models for genetic influences on age of onset for Alzheimer disease: Findings in Swedish twins. Am J Med Genet 105(8):724-728.
33. Pericak-Vance MA, Grubber J, Bailey LR, Hedges D, West S, Santoro L, Kemmerer B, Hall JL, Saunders AM, Roses AD, et al. 2000. Identification of novel genes in late-onset Alzheimer's disease. Exp Gerontol 35(9-10):1343-1352.
34. Schaid DJ, Jacobsen SJ. 1999. Biased tests of association: Comparisons of allele frequencies when departing from Hardy-Weinberg proportions [comment]. Am J Epidemiol 149(8):706-711.
35. Shaag A, Saada A, Berger I, Mandel H, Joseph A, Feigenbaum A, Elpeleg ON. 1999. Molecular basis of lipoamide dehydrogenase deficiency in Ashkenazi Jews. Am J Med Genet 82(2):177-182.
36. Sheehe PR. 1966. Combination of log relative risk in retrospective studies of disease. Am J Public Health Nat Health 56(10):1745-1750.
37. Shoffner JM. 1997. Oxidative phosphorylation defects and Alzheimer's disease. Neurogenetics 1(1):13-19.
38. Single RM, Meyer D, Hollenbach JA, Nelson MP, Noble JA, Erlich HA, Thomson G. 2002. Haplotype frequency estimation in patient populations: The effect of departures from Hardy-Weinberg proportions and collapsing over a locus in the HLA region. Genetic Epidemiol 22(2):186-195.
39. Sorbi S, Bird ED, Blass JP. 1983. Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann Neurol 13(1): 72-78.
40. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. 1993. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90(5):1977-1981.
41. Terwilliger JD, Ott J. 1994. Handbook of human genetic linkage. Baltimore: Johns Hopkins.
42. Tripatara A, Korotchkina LG, Patel MS. 1999. Characterization of point mutations in patients with pyruvate dehydrogenase deficiency: Role of methionine-181, proline-188, and arginine-349 in the alpha subunit. Arch Biochem Biophys 367(1):39-50.
43. Wallace DC, Shoffner JM, Trounce I, Brown MD, Ballinger SW, Corral-Debrinski M, Horton T, Jun AS, Lott MT. 1995. Mitochondrial DNA mutations in human degenerative diseases and aging. Biochim Biophys Acta 1271(1):141-151.
44. Wallace DC, Stugard C, Murdock D, Schurr T, Brown MD. 1997. Ancient mtDNA sequences in the human nuclear genome: A potential source of errors in identifying pathogenic mutations. Proc Natl Acad Sci USA 94(26):14900-14905.
45. Warwick Daw E, Payami H, Nemens EJ, Nochlin D, Bird TD, Schellenberg GD, Wijsman EM. 2000. The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet 66(1):196-204.
46. Yates CM, Butterworth J, Tennant MC, Gordon A. 1990. Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. J Neurochem 55(5):1624-1630.
47. Zak NB, Shifman S, Shalom A, Darvasi A. 2001. Population-based gene discovery in the post-genomic era. Drug Discov Today 6(21):1111-1115.
48. Zaykin D, Zhivotovsky L, Weir BS. 1995. Exact tests for association between alleles at arbitrary numbers of loci. Genetica 96(1-2):169-178.